Zusammenfassung
Die Forschung der letzten 15 Jahre hat zahlreiche neue Erkenntnisse über die Entstehung des ascites erbracht. Leider ist die Literatur über dieses Thema sehr verstreut, so daß ein Überblick erschwert ist. Im folgenden wird zusammenfassend über dieses große Gebiet berichtet.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Adlercrexjtz, E.: Intraperitoneal infusion of ultrafiltered ascites in decompensated cirrhosis of the liver. Acta med. scand. 161, 1–20 (1958).
Albeaux-Fernet, M., and J. R. M. Franckson: Contribution a l’étude du métabolisme des hormones stéroides chez l’homme atteint d’affections hépatiques. I. Epreuve de surcharge and clearance androgénique. Ann. Endoer. (Paris) 13, 35–54 (1952).
Alexander, R. S.: Reflex alterations in venomotor tone produced by venous congestion. Circulât. Res. 4, 49–53 (1956).
Allen, P. B. R., S. Kling and K. Kowalewski: Effects of gradual complete occlusion of hepatic veins in dogs. Proc. Soc. exp. Biol. (N. Y. ) 98, 894–897 (1958).
Amatuzio, D. S., F. Stutzman, N. Schrifter and S. Nesbitt: A study of serum electrolytes (Na, K, Ca, P) in patients with severely decompensated portal cirrhosis of the liver. J. Lab. clin. Med. 39, 26–29 (1952).
Baggenstoss, A. H., and J. C. Cain: Further studies on the lymphatic vessels at the hilus of the liver of man: their relation to ascites. Proc. Mayo Clin. 32, 615–627 (1957).
The hepatic hilar lymphatics of man: their relation to ascites. New Engl. J. Med. 256, 531–535 (1957).
Baker, L., R. C. Puestow, S. Kruger and J. H. Last: Estimation of ascitic fluid volumes. J. Lab. clin. Med. 39, 30–35 (1952).
Ball, W. C., J. O. Davis and M. J. Goodkind: Ascites formation without sodium intake in dogs with thoracic inferior vena cava constriction and in dogs with right-sided congestive heart failure. Amer. J. Physiol. 188, 578–582 (1957).
Baronofsky, I. D., R. E. Faucett and H. A. Weiss: Total adrenalectomy in the treatment of intractable ascites. J. Amer. med. Ass. 172, 231–235 (1960).
Bartter, F. C., and P. Fourman: The different effects of aldosterone-like steroids and hydrocortisone-like steroids on urinary excretion of potassium and acid. Metabolism 11, 6–20 (1962).
Bartter, F. C. G. W. Liddle, L. E. Duncan, J. K. Barber and C. Delea: The regulation of aldosterone secretion in man: the role of fluid volume. J. clin. Invest. 35, 1306–1315 (1956).
Bateman, J. C., H. M. Shorr and T. Elgvin: Hypervolemic anemia in cirrhosis. J. clin. Invest. 28, 539–547 (1949).
Bauer, F. K., W. H. Blahd and M. Fields: Ascitic fluid and plasma protein exchange. Studies with radioiodinated human serum albumin. J. clin. Invest. 32, 553–554 (1953).
Bean, W. B., W. D. Paul and M. Franklin: Preliminary studies on an indirect method for determining portal pressures. J. clin. Invest. 28, 769–770 (1949).
Belli, L., A. Peracchia and F. Pisani: Prevention and treatment of ascites: an experi-mental approach of the problem by intraperitoneal liver exclusion. Exp. Med. Surg. 16, 29–40 (1958).
Bergstrom, W. H., and W. M. Wallace: Bone as a sodium and potassium reservoir. J. clin. Invest. 33, 867–873 (1954).
Berson, A. S., and R. S. Yalow: The distribution of 131-I-labeled human serum albumin introduced into ascitic fluid: Analysis of the kinetics of a three compartment catenary transfer system in man and speculations on possible sites of degradation. J. clin. Invest. 33, 377–387 (1954).
Bierman, H. R., H. L. Steinbach and L. P. White: Portal venipuncture. A percutaneous, trans-hepatic approach. Proc. Soc. exp. Biol. (N. Y. ) 79, 550–552 (1952).
Biserte, G., A. Tacquet, F. Guerrin and R. Havez: Etude électrophorétique des complexes protéiques des liquides d’ascite. Arch. Mal. Appar. dig. 47, 215–220 (1958).
Bjorneboe, M., C. Brun and F. Raaschou: Colloid osmotic pressure in chronic hepatitis. Arch, intern. Med. 83, 539–546 (1949).
Blakemore, A. H.: Portacaval anastomosis. A report on fourteen cases. Bull. N. Y. Acad. Med. 22, 254–263 (1946).
Blakemore, A. H. Indications for portacaval anastomosis–Analysis of cases. Surg. Gynec. Obstet. 84, 645–653 (1947).
Bolton, C.: On the pathology of the dropsy produced by obstruction of the superior and inferior venea cavae and the portal vein. Proc. roy. Soc. B 79, 267–283 (1907).
Brandley, S. E., P. A. Marks, P. C. Reynell and J. Meltzer: The circulating splanchnic blood volume in dog and man. Trans. Ass. Amer. Phycns 66, 294–302 (1953).
Britton, R. C., and J. Nakamoto: Intravenous infusion of dialysed, autogenous ascitic fluid in the management of cirrhotic ascites. Cleveland Clin. Quart. 27, 82–87 (1960).
Brugel, H.: Probleme der portalen Hypertension. Dtsch. med. Wschr. 78, 711–715, 747–750 (1953).
Cachera, R., F. Darnisetg. Lepercq: Volume plasmatique, protéines totales circulantes and syndrome oedémateux des cirrhoses alcooliques. Presse méd. 59, 1660–1664 (1951).
Cachera, R. and M. Rapin: L’hormone thyroïdienne dans le traitement des épanchements cirrhotiques. France méd. 19 (No 2), 5–12 (1956).
Cameron, C. B.: Steroid hormone metabolism. Brit. med. Bull. 13, 119–125 (1957).
Canter, J. W., I. Kreel, R. L. Segal, A. Frankel and I. D. Baronofsky: Influence of thyroidectomy on experimental ascites. Proc. Soc. exp. Biol. (N. Y. ) 100, 771–774 (1959).
Chabrol, E., A. Giraud and P. Fallot: Treatment of cirrhosis with perfusions of ascitic fluid. J. Amer. med. Ass. 147, 774 (1951).
Chabrol, E, A. Giraud, P. Fallot and J. Raynaud: L’autoperfusion ascitique en pro- téinothérapie. Paris méd. 187, 214–218 (1949).
Chagoya, L., B. Nurko, E. SantoS and A. Rivera: 6-ehloro, 6-dehydro, 17A-acetoxy- progesterone: its possible action as an aldosterone antagonist. J. clin. Endoer. 21, 1364 to 1375 (1961).
Chart, J. J., E. S. Gordon, P. Helmer and M. Lesher: Metabolism of salt-retaining hormone by surviving liver slices. J. clin. Invest. 35, 254–260 (1960).
Cherrick, G. R., D. N. S. Kerr, A. E. Read and S. Sherlock: Colloid osmotic pressure and hydrostatic pressure relationship in the formation of ascites in hepatic cirrhosis. Clin. Sei. 19, 361–375 (1960).
Clowdus, B. F., J. A. Higgins, J. W. Rosevear and W. H. J. Summerskill: Treatment of “refractory” ascites with a new aldosterone antagonist in patients with cirrhosis. Proc. Mayo Clin. 35, 97–105 (1960).
Clowdus, B. F., W. H. J. Summerskill, T. H. Gasey, J. A. Higgins and A. L. Orvis: Isotope studies of the development of water and electrolyte disorders and azotemia during the treatment of ascites. Gastroenterology 41, 360–370 (1961).
Cohen, S., T. Freeman and A. S. Mcfarlane: Metabolism of 131-I-labelled human albumin. Clin. Sei. 20, 161–170 (1961).
Combrisson, A. G., J. Debray and E. Housset: Intérêt du dosage de certains facteurs de coagulation dans le liquide d’ascite. Mise en évidence d’un test caractérisant l’ascite d’origine cirrhotique. Presse méd. 65, 1227–1228 (1957).
Conn, J. W., and L. H. Louis: Production of endogenous “salt-active” corticoids as reflected in the concentrations of sodium and chloride of thermal sweat. J. clin. Endoer. 10, 12–23 (1950).
Coombs, H. C.: The mechanism of the regulation of intraabdominal pressure. Amer. J. Physiol. 61, 159–170 (1922).
Craig, R. L., R. E. Ranney, N. Wetzel and R. G. Bianchi: The effect of radiothyroid- ectomy on experimental ascites. Quart. Bull. Northw. Univ. med. Sch. 35, 197–202 (1961).
Craig, R. L., and Wetzel, N.: The effect of hypophysectomy on ascites due to circulatory failure on dog. Quart. Bull. Northw. Univ. med. Sch. 28, 55–56 (1954).
Craig, R. L., and Wetzel, N.:The effect of hypophysectomy on accumulated ascites due to circulatory failure in the dog. Ann. Surg. 140, 535–538 (1954).
Craig, R. L. and R. A. Bianchi: The effect of replacement treatment on experimental ascites relived by hypophysectomy. Quart. Bull. Northw. Univ. med. Sch. 30, 205–212 (1956).
Craig, R. L. and R. A. BianchI: Experimental ascites treated by hypophysectomy and substitution therapy. Quart. Bull. Northw. Univ. med. Sch. 33, 201–205 (1959).
Cross, F. S., F. L. Raffucci, R. W. Toon and O. H. Wangensteen: Effect of complete hepatic vein ligation on portal pressures and ascites formation in dogs with porta-caval shunts. Proc. Soc. exp. Biol. (N. Y. ) 82, 505–509 (1953).
D’amico, G.: La ritenzione del sodio come cause dell’ascite nella cirrosi di Morgagni Laennec. Arch. Pat. Clin. med. 32, 353–373 (1956).
Davidson, C. S., T. B. Gibbons and W. W. Faloon: Systemic and portal venous pressures in cirrhosis of the liver. J. Lab. clin. Med. 35, 181–187 (1950).
Davis, H. A., and J. F. Blalock: Autologous and homologous transfusion of human ascitic fluid. J. clin. Invest. 18, 219–224 (1939).
Davis, H. A., and C. S. White: Human ascitic fluid as a blood substitute in experimental secondary shock. Proc. Soc. exp. Biol. (N. Y. ) 38, 462–465 (1938).
Davis, J. O., R. C. Bahn, N. A. Yankopoulos, B. Kliman and R. E. Peterson: Acute effects of hypophysectomy and diencephalic lesions on aldosterone secretion. Amer. J. Physiol. 197, 380–386 (1959).
Davis, J. O., and W. C. Ball: Effects of a body cast on aldosterone and sodium excretion in dogs with experimental ascites. Amer. J. Physiol. 192, 538–542 (1958).
Davis, J. O., C. C. J. Carpenter, C. R. Ayers, J. E. Holman and R. C. Bahn: Evidence for secretion of an aldosterone-stimulating hormone by the kidney. J. clin. Invest. 40, 684–696 (1961).
Davis, J. O., D. S. Howell and J. L. Southworth: Mechanisms of fluid and electrolyte retention in experimental preparations in dogs. III. Effect of adrenalectomy and subsequent desoxycorticosterone acetate administration on ascites formation. Circulât. Res. 1, 260–270 (1953).
Dawson, A. D.: Historical notes on ascites. Gastroenterology 39, 790–791 (1960).
Devig, G., J. Feroldi, P. Dejaques and P. Mallet-Guy: Etude expérimentale des ascites: sténoses veineuses posthépatiques and transposition du foie dans le thorax. Bull. Soc. int. Chir. Brüx. 15, 48–52 (1956).
Dies, F., and A. Rivera: Mecanismos de la formación de ascitis en enfermos con cirrosis del higado I–III.–Rev. Invest, clin. 13, 139–195 (1961).
Egert, H., R. Höfer U. A. Neumayr: Untersuchungen des Albuminumsatzes bei Leber-krankheiten. Klin. Wschr. 40, 134–137 (1962).
Eisenberg, S.: Blood volume in patients with Laennec’s cirrhosis of the liver as determined by radioactive chronium-tagged red cells. Amer. J. Med. 20, 189–195 (1956).
Eisenmenger, W. J., S. H. Blondheim, A. M. Bongiovanni and H. G. Kunkel: Electrolyte studies on patients with cirrhosis of the liver. J. clin. Invest. 29, 1491–1499 (1950).
Eisenmenger, W. J, and W. F. Nickel: Relationship of portal hypertension to ascites in Laennec’s cirrhosis. Amer. J. Med. 20, 879–889 (1956).
Emile-Weil, P., and P. Isch-Wall: Hémo-agglutinines des divers liquides organiques. C. R. Soc. Biol. (Paris) 88, 173–175 (1923).
Enquist, I. F., R. G. Aiello, B. S. Levowitz and E. Ikezono: An attempt to determine the source of experimental ascitic fluid. Surg. Forum 9, 561–565 (1958).
Eppinger, H.: Die Leberkrankheiten. Wien: Springer 1937.
Etienne-Martin, P., CL. Klepping and J. Guerrin: La traitement de l’oedème des cirrhoses hépatiques par une spirolactone 1’Aldactone. Lyon méd. 93, 1095–1104 (1961).
Faloon, W. W., R. D. Eckhardt, A. M. Cooper and C. S. Davidson: The effect of human serum albumin, mercurial diuretics, and low sodium diand on sodium excretion in patients with cirrhosis of the liver. J. clin. Invest. 28, 595–602 (1949).
T. L. Murphy, A. M. Cooper and C. S. Davidson: An evaluation of human serum albumin in the treatment of cirrhosis of the liver. J. clin. Invest. 28, 583–594 (1949).
Ferris, E. B., and R. W. Wilkins: The clinical value of comparative measurements of the pressure in the femoral and cubital veins. Amer. Heart J. 13, 431–439 (1937).
Fisher, B., C. Russ, E. Fedor, R. Wilde, P. Engstrom and E. R. Fisher: Further experimental observations on animals with arterialized livers. Surgery 38, 181–193 (1955).
Flandrin, P., J. Groulade, D. Hollard and M. Rachail: Etude de l’action de la spirolactone dans la cirrhose éthylique oedémateuse. Lyon méd. 93, 1125–1137 (1961).
Fleisher, G. A., L. G. Bartholomew, J. C. Cain and R. A. Rovelstad: Ascites. II. The value of determinations of enzymes in the study of ascitic fluid. Gastroenterology 37, 325–338 (1959).
Ford, R. V.: Diuretic therapy of congestive heart failure. Ann. N. Y. Acad. Sei. 71, 397–408 (1958).
Freeman, S.: Recent progress in the physiology and biochemistry of the liver. Med. Clin. N. Amer. 37, 109–124 (1953).
Gabuzda, G. J., and C. S. Davidson: Protein metabolism in patients with cirrhosis of the liver. Ann. N. Y. Acad. Sei. 57, 776–785 (1954).
Gabuzda, G. J., H. S. Traeger and C. S. Davidson: Hepatic cirrhosis. Factors contributing to the failure to excrete urinary sodium during the accumulation of ascites and edema. J. clin. Invest. 29, 814 (1950).
Gage, A. A., R. W. Mcgrath, M. J. Gianturco and C. G. Santoro: The amelioration of experimental ascites by hepatopexy. Surg. Forum 8, 244–247 (1957).
Ganong, W. F., and P. J. Mulrow: Evidence of secretion of an aldosterone-stimulating substance by the kidney. Nature (Lond.) 190, 1115–1117 (1961).
Gantt, C. L., and J. M. Dyniewicz: Some effects of 17-spirolactosteroids on the edema of cirrhosis, with observations on a new spirolactone derívate. Clin. Res. 7, 294 (1959).
Germer, W. D.: Milzexstirpation bei splenomegaler Lebercirrhose mit Zytopenie. Dtsch. med. Wschr. 81, 1884–1889 (1956).
Germer, W. D., U. E. Regoeczi: Ein experimenteller Beitrag zur Testosteronwirkung bei toxischen Leberschäden. Dtsch. Arch. klin. Med. 205, 343–361 (1958).
Germer, W. D., U. H. Choi: Über die hepatische Fibrose bei der Ratte. Z. exp. Med. 131, 238–245 (1959).
Ghiringhelli, L.: Osservazioni sull’aldosteronuria negli epatopazienti. Minerva med. (Torino) 51, 4464–4469 (1960).
Gibson, J. B.: Hepatic lesions and ascites in experimental longterm constriction of the inferior vena cava in the rat. Brit. J. exp. Path. 40, 183–194 (1959).
Gilder, H., G. N. Cornell, E. A. Free and G. Johnson: Dilution studies in dogs with experimental ascites. Metabolism 7, 201–212 (1958).
Gilder, H., H. J. Mannix: Renal function in experimental ascites. Metabolism 5, 51–57 (1956).
Gilder, H. S. F. Redo and D. Barr: Water distribution in patients with Laennec’s cirrhosis using radioactive sodium. Surg. Forum 4, 578–584 (1953).
Gilder, H. and C. G. Child III: Water distribution in normal subjects and in patients with Laennec’s cirrhosis. J. clin. Invest. 33, 555–564 (1954).
Girard, M., A. Bel, J. Guillermet, J. Michel and F. Bothier: Premiers essais de traitement du syndrome oedémateux des cirrhoses hépatiques par les spirolactones. Lyon méd. 93, 1055–1071 (1961).
Girard, M., H. Fraisse and R. Chabanon: Essai de traitement de la cirrhose alcoolique par les perfusions d’ascite. Arch. Mal. Appar. dig. 38, 910–921 (1949).
Girotjd, C. J. P., M. Saffran, A. V. Schall Y, J. Stachenko and E. H. Venning: Production of aldosterone by rat adrenal glands in vitro. Proc. Soc. exp. Biol. (N. Y. ) 92, 855–859 (1956).
Giuseffi, J., E. E. Werk, P. U. Larson, L. Schiff and D. W. Elliott: Effect of bilateral adrenalectomy in a patient with massive ascites and postnecrotic cirrhosis. New Engl. J. Med. 257, 796–803 (1957).
Goodyer, A. V. N., A. S. Relman, F. D. Lawrason and F. H. Epstein: Salt retention in cirrhosis of the liver. J. clin. Invest. 29, 973–981 (1950).
Gordon, E. S.: Inactivation of salt-retaining hormone by the liver. J. Lab. clin. Med. 44, 803–804 (1954).
Gordon, M. E.: The acute effects of abdominal paracentesis in Laennec’s cirrhosis upon exchange of electrolvtes and water, renal function and hemodynamics. Amer. J. Gastro- ent. 33, 15–37 (I960).
Goswami, B. M.: Role of aldosterone in clinical medicine. Curr. med. Pract. 5, 565–567 (1961).
Gray, H. K.: Clinical and experimental investigation of the circulation of the liver. Ann. roy. Coll Surg. Engl. 8, 354–365 (1951).
Greene, C. H.: Physiologic considerations in the treatment of portal cirrhosis. J. Amer, med. Ass. 121, 715–719 (1943).
Griffith, J. Q., and H. R. Hansell: Studies on the effect of abdominal pressure on urine volume. Amer. J. Physiol. 74, 16–21 (1925).
Hartmann, L.: Zit. nach Hirsch-Marie. Sem. Hop. Paris 37, 2707–2713 (1961).
Hastings, A. B., H. A. Salvesen, J. Sendroy and D. D. Van Slyke: Studies of gas and electrolyte equilibria in the blood. IX. The distribution of electrolytes between transsudates and serum. J. gen. Physiol. 8, 701–711 (1927).
Hecker, R., and S. Sherlock: Electrolyte and circulatory changes in terminal liver failure. Lancand II, 1121–1125 (
Hellman, S., and W. W. Faloon: The sodium excretion defect in hepatic cirrhosis studied by the use of a steroidal lactone. J. Lab. clin. Med. 55, 872–882 (1960).
Hirsch-Marie, H., and R. Cattan: Sur l’étude des protéines dans les liquides d’ascite emploi de l’électrophorèse, de l’immuno-chimie and du diagramme de solubilité des euglobulines. Sem. Hôp. Paris 37, 2707–2713 (1961).
Hoffbauer, F. W., J. L. Bollman and J. L. Grindlay: Factors influencing pressure in the portal vein as studied in the intact animal. Gastroenterology 16, 194–210 (1950).
Howell, D. S., and J. O. Davis: Relationship of sodium retention to potassium excretion by the kidney during administration of desoxycorticosterone acetate to dogs. Amer. J. Physiol. 179, 359–363 (1954).
Hurter, R., and J. D. N. Nabarro: Aldosterone metabolism in liver disease. Acta endocr. (Kbh. ) 33, 168–174 (1960).
Hwang, W., L. C. Akman, A. J. Miller, E. N. Silber, J. Stamler and L. N. KATZ: Effects of sustained elevation of renal venous pressure on sodium excretion in un- anesthetized dog. Amer. J. Physiol. 162, 649–654 (1950).
Hyatt, R. E., and J. R. Smith: The mechanism of ascites. Amer. J. Med. 16, 434–448 (1954).
Hyde, G. M., N. I. Berlin, R. J. Parsons, J. H. Lawrence and S. Port: The blood volume in portal cirrhosis as determined by32P-labeled red blood cells. J. Lab. clin. Med. 39, 347–353 (1952).
Inversen, P., U. F. Nakazawa: Über die Biochemie des Filtrationsödems. Biochem. Z. 191,307–319(1927).
Ivanyi, J.: Die Aldosteron-Antagonisten. Dtsch. med. J. 12, 554–557 (1961).
Jacobson, J. H., J. Laragh and F. F. Mcallister: The experimental production of reversible state of chronic progressiv edema. Surg. Forum 7, 45–47 (1956).
Jagt, T., and O. A. Larsen: Determination of lactic dehydrogenase in ascitic fluid from patients with malignant tumors. Scand. J. clin. Lab. Invest. 12, 200–204 (1960).
Johnson, B. B., A. H. Lieberman and P. J. Mulrow: Aldosterone excretion in normal subjects depleted of sodium and potassium. J. clin. Invest. 36, 757–766 (1957).
Jones, K. M., R. Lloyd-Jones, A. Riondel, J. F. Tait, S. A. S. Tait, R. D. Bulbrook and F. C. Greenwood: Aldosterone secretion and metabolism in normal men and women and in pregnancy. Acta endocr. (Kbh. ) 30, 321–342 (1959).
Jovino, R., e R. Cokdurso: Sul valore diagnostico e sul significato clinico del dossaggio della protrombina nei liquidi ascitici. Rss. int. Clin. Ter. 40, 745–749 (1960).
Justin-Besançon, L., CL. Laroche, A. Nenna, J. -P. Etienne and G. CREMER: Les spirolactones. Leur utilisation dans le traitement des oedèmes cardiaques and cirrhotiques. Sem. thér. 37, 197–211 (1961).
Kagawa, C. M., J. A. Cella and C. G. Van Arman: Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt. Science 126, 1015–1016 (1957).
Kark, R. M.: Low sodium and high protein diets in Laennec’s cirrhosis. Med. Clin. N. Amer. 35, 73–91 (1951).
King, H., R. E. Lempke, R. D. King and G. C. Kaiser: Metabolic observations during continuous intravenous infusion of ascitic fluid. Surg. Forum 12, 347–348 (1961).
Kinsell, L. W., S. Margen, H. Tarver, J. M. B. Frantz and E. K. Flanagan: Studies in protein metabolism with the aid of 35S-labeled methionine. J. clin. Invest. 28, 793 (1949).
Kling, S., and P. B. R. Allen: The effects of gradual, complete occlusion of the hepatic veins. Surg. Forum 9, 550–553 (1958).
Knauff, H. G., H. Selmair U. H. Zickgraf: Die freien Aminosäuren in Ascites- und Pleurapunktaten. Hoppe-Seylers Z. physiol. Chem. 318, 73–81 (1960).
Kreel, I., J. W. Canter, R. L. Segal, A. FrankeL and I. D. Barnofsky: The influence of thyroidectomy on experimental ascites. Surg. Forum 10, 125–128 (1959).
Kunkel, H. G., and W. J. Eisenmenger: Increased portal pressure and ascites in rats following ligation of the portal vein. Proc. Soc. exp. Biol. (N. Y. ) 71, 212–213 (1949).
Kunkel, H. G., D. H. Labby, E. H. Ahrens, R. E. Shank and C. L. Hoagland: The use of concentrated human serum albumin in the treatment of cirrhosis of the liver. J. clin. Invest. 27, 305–319 (1948).
Kwaan, H. C., K. S. Lai and A. J. S. Mcfadzean: Lysokinase activitv in ascitic fluid. Lancand 1960 I, 1327–1329.
Laragh, J. H.: The effect of potassium chloride on hyponatremia. J. clin. Invest. 33, 807–818 (1954).
Ledingham, J. G. G., F. I. R. Martin, A. Moxham, R. Hurter and J. D. N. Nabarro: The metabolic effects of aldosterone given by mouth. Lancand 1961 1, 630–632.
Lee, S. H.: The production of experimental ascites and experiences in treatment with the rectus wick operation. Surg. Forum 9, 557–561 (1958).
Le Veen, H. H., and W. H. Fishman: Combination of Evans Blue with plasma proteins: its significance in capillary permeability studies, blood dye disappearance curves, and its use as a protein tag. Amer. J. Physiol. 151, 26–33 (1947).
Levrat, M., R. Brette, B. François, A. Tissot and G. Mestrallet: Essais de traitement des ascites cirrhotiques par une spirolactone. Lyon méd. 93, 1115–1123 (1961).
Levy, L. K., and G. E. Burch: Studies on venous pressure in hepatic cirrhosis. Ann. intern. Med. 29, 274–277 (1948).
Liddle, W. G.: Sodium diuresis induced by steroidal antagonists of aldosterone. Science 126, 1016–1018 (1957).
Linquette, M., and P. FossatI: Régulation de la sécrétion de l’aldosterone. Lille méd. 6, 689–696 (1961).
Lockwood, C. H.: Spirolactone (Aldactone) therapy for ascites due to cirrhosis of the liver. Canad. med. Ass. J. 85, 631–637 (1961).
Lods, J. C.: Physiologie de la veine porte. Rev. int. Hépat. 11, 409–422 (1961).
Loeb, R. F., D. W. Atchley and W. W. Palmer: On the equilibrium conditions between blood serum and serous cavity fluids. J. gen. Physiol. 4, 591–595 (1922).
Longmire, W. P., D. G. Mulder, P. S. Mahoney and S. W. Mellinkoff: Side-to-side portacaval anastomosis for portal hypertension. Ann. Surg. 147, 881–894 (1958).
Luetscher, J. A. jr.: Electrophoretic analysis of the proteins of plasma and serous effusions. J. clin. Invest. 20, 99–106 (1941).
Madden, J. L., J. M. Lore, F. P. Gerold and J. M. Ravid: The pathogenesis of ascites and a consideration of its treatment. Surg. Gynec. Obstet. 99, 385–391 (1954).
Mankin, H., and A. Lowell: Osmotic factors influencing the formation of ascites in patients with cirrhosis of the liver. J. clin. Invest. 27, 145–153 (1948).
Marko Witz, J.: Experimental Surgery, p. 485. 2. edit. Baltimore: Williams & Wilkins Co. 1949.
Marson, F. G. W.: Total adrenalectomy in hepatic cirrhosis with ascites. Lancand II, 847–848 1954.
Mcgtjckin, W. F., E. H. Soule, J. C. Cain, L. G. Bartholomew and R. A. Rovel- Stad: Ascites. III. The value of glycoprotein determination and cytology in the study of ascitic fluid. Gastroenterology 37, 332–338 (1959).
Mckee, F. W., J. A. Schilling, G. H. Tishkoff and R. E. Hyatt: Experimental ascites. Effects of sodium chloride and protein intake on protein metabolism of dogs with constricted inferior vena cava. Surg. Gynec. Obstet. 89, 529–540 (1949).
Mckee, F. W., P. R. Schloerb, J. A. Schilling, G. H. Tishkoff and G. H. Whipple: Protein metabolism and exchange as influenced by constriction of the vena cava. J. exp. Med. 87, 457, 471 (1948).
Mckee, F. W., W. G. Wilt, R. E. Hyatt and G. H. Whipple: The circulation of ascitic fluid. Interchange of plasma and ascitic fluid as studied by means of 14C-labeled lysine in dogs with constriction of the vena cava. J. exp. Med. 91, 115–122 (1950).
Mckee, F. W., C. L. Yuile, B. G. Lamson and G. H. Whipple: Albumin and globulin circulation in experimental ascites. J. exp. Med. 95, 161–172 (1952).
Mehrotra, R. M. L., V. S. Mangalik and N. C. Nayak: An experimental study of the effect of DOCA on the development of ascites in CC14 cirrhosis. Indian J. med. Res. 45, 183–190 (1957).
Meigs, J. V.: Fibroma of the ovary with ascites and hydrothorax–Meigs’ syndrome. Amer. J. Obstet. 67, 962–985 (1954).
Mendelsohn, M., and O. H. Pearson: Alterations in water and salt metabolism after bilateral adrenalectomy in man. J. clin. Endoer. 15, 409–423 (1955).
Michon, P., R. Dornier and CL. Kling: Liquide ascitique thermiquement concentré en autoperfusion dans les cirrhoses. Thérapie 10, 569–578 (1955).
Michon, P., and CL. Kling: Auto-reprotéinisation par perfusion de liquide d’ascite ayant subi la concentration thermique. Rev. méd. Nancy 80, 113–115 (1955).
Mittelmann, A., O. Gore and H. G. Barker: The effects of portacaval shunting on urinary aldosterone excretion. Surg. Forum 10, 291–294 (1959).
Morrison, R. S., and T. C. Chalmers: Combined diuretic and steroid therapy in cirrhosis with ascites. Ann. N. Y. Acad. Sei. 88, 907–914 (1960).
Murray, J. F., A. M. Davidson and S. Sherlock: Circulatory changes in chronic liver disease. Amer. J. Med. 24, 358–367 (1958).
Muzzolini, M.: Le asciti lattescenti. Progr. med. (Napoli) 12, 112–117 (1956).
Myers, W. K., and C. S. Keefer: Relation of plasma protein to ascites and edema in cirrhosis of the liver. Arch, intern. Med. 55, 349–359 (1935).
Naegeli, Th., U. Fr. Meythaler: Experimentelle Untersuchungen über arteriovenöse Gefäßanastomosen der Lebergefäße. Dtsch. Z. Chir. 240, 88–91 (1933).
Nix, J. T., F. C. Mann, J. L. BOllman, J. H. Grindlay and E. V. Flock: Alterations of protein constituents of lymph by specific injury to the liver. Amer. J. Physiol. 164, 119–122 (1951).
Oeff, K., U. P. Körtge: Abbau und Verteilung von 131J-markiertem Albumin bei Normalpersonen und Patienten mit Lebercirrhose. Klin. Wschr. 34, 75–80 (1956).
Ohne Autor: L’auto-transfusione di liquido ascitico nellacirrosi epatica. Policlinico, Sez. prat. 64, 162–164 (1957).
Ohne Autor: Control of aldosterone secretion. Brit. med. J. II, 553–554, 1959.
Oldershausen, V. H. -F., U. E. Regoeczi: Über Serumfermentaktivitäten bei der Leber-cirrhose und ihren Vorstadien unter besonderer Berücksichtigung des chronischen Alkoholismus. Bibl. Gastroent. (Basel) 4, 79–89 (1961).
Orloff, M. J., and G. B. Snyder: Experimental ascites. I. Production of ascites by gradual occlusion of the hepatic veins with an internal vena caval cannula. Surgery 50, 789–797 (1961).
Orti, E., E. P. Ralli, B. Laken and M. E. Dumm: Presence of an aldosterone stimulating substance in the urine of rats deprived of salt. Amer. J. Physiol. 191, 323– 328 (1957).
Paneth, J.: Über den Einfluß venöser Stauung auf die Menge des Harns. Pflügers Arch, ges. Physiol. 39, 515–555 (1886).
Paolino, W., A. Amerio E F. Gavosto: Studio di uno caso di cirrosi epatica sottoposto a transfusioni di ascite, ascite concentrata e di plasma. Minerva med. (parte sei. ) 41 (I), 205–211 (1950).
Papper, S.: The role of the kidney in Laennec’s cirrhosis of the liver. Medicine 37, 299–316 (1958).
Papper, S., and L. Saxon: The influence of intravenous infusions of sodium chloride solutions on the renal excretion of sodium in patients with cirrhosis of the liver. J. clin. Invest. 35, 728 (1956).
Patek, A. J., H. Mankin, H. Colcher, A. Lowell and D. P. Earle: The effects of intravenous injection of concentrated human serum albumin upon blood plasma, ascites and renal functions in three patients with cirrhosis of the liver. J. clin. Invest. 27, 135–144 (1948).
Pattison, A. C., and T. B. Reynolds: Medical and surgical aspects of portal hypertension. Med. Clin. N. Amer. 43, 1141–1153 (1959).
Perera, G. A.: The plasma volume in Laennec’s cirrhosis of the liver. Ann. intern. Med. 24, 643–647 (1946).
Pickert, H.: Patho-physiologische Aspekte des Ascitesproblems. Dtsch. med. J. 10, 430–432 (1955).
Pickert, H. Klinische Ascitesprobleme. Ärztl. Wschr. 11, 1125–1132 (1956).
Popper, H., H. Elias and D. E. Petty: Vascular pattern of cirrhotic liver. Amer. J. clin. Path. 22, 717–729 (1952).
Post, J., and A. J. Patek: Serum proteins in cirrhosis of the liver. I. Relation to prognosis and to formation of ascites. Arch, intern. Med. 69, 67–82 (1942).
Serum proteins in cirrhosis of the liver. II. Nitrogen balance studies in five patients. Arch, intern. Med. 69, 83–89 (1942).
Prentice, T. C., W. Siri and E. E. Joiner: Quantitative studies of ascitic fluid circulation with tritium-labeled water. Amer. J. Med. 13, 668–673 (1952).
Purjesz, I., L. Ritter, G. Urban and P. Weisz: Hyposmosis and aldosterone secretion. Acta physiol. Acad. Sei. hung. 17, 443–448 (1960).
Raisz, L. G., W. F. Mcneely, L. Saxon and J. D. Rosenbaum: The effects of cortisone and hydrocortisone on water diuresis and renal function in man. J. clin. Invest. 36, 767–779 (1957).
Ralli, E. P., J. S. Robson, D. Clarke and C. L. Hoagland: Factors influencing ascites in patients with cirrhosis of the liver. J. clin. Invest. 24, 316–325 (1945).
Reemtsma, K., R. E. Carlson, D. V. Habif and H. G. Barker: Changes in sodium metabolism following portacaval shunts in patients with cirrhosis and ascites. Surg. Forum 7, 422–425 (1956).
Regoeczi, E., U. W. D. Germer: Experimentelle Beobachtungen über die Wirkung des Testosteron Propionates bei diätetischer Lebernekrose. Dtsch. Arch. klin. Med. 205, 624–639 (1959).
Beobachtungen bei Ascites-Autoperfusion an Patienten mit Lebercirrhose. Dtsch. Arch. klin. Med. 207, 621–636 (1962).
Ricketts, W. E., L. Eichelberger and J. B. Kirsner: Observations on the alterations in electrolytes and fluid balance in patients with cirrhosis of the liver with and without ascites. J. clin. Invest. 30, 1157–1170 (1951).
Roberts, K. E., and H. T. Randall: The effect of adrenal steroids on renal mechanisms of electrolyte excretion. Ann. N. Y. Acad. Sei. 61, 306–314 (1955).
Ross, E. J., W. J. Reddy, A. Rivera and G. W. Thorn: Effects of intravenous infusions of dl-aldosterone acetate on sodium and potassium excretion in man. J. clin. Endocr. 19, 289–296 (1959).
Rousselot, L. M.: Congestive splenomegaly (Banti’ syndrome). Bull. N. Y. Acad. Med. 15, 188–196 (1939).
Rousselot, L. M., and W. P. Thomson: Experimental production of congestive splenomegaly. Proc. Soc. exp. Biol. (N. Y. ) 40, 705–708 (1939).
Rovelstad, R. A., L. G. Bartholomew and J. C. Cain: Ascites. IV. Clinical appraisal of the laboratory studies of ascitic fluid and blood as an aid to diagnosis. Gastroenterology 37, 339–345 (1959).
B. F. Mckenzie and E. H. Soule: Ascites. I. The value of examination of ascitic fluid and blood for lipids and for proteins by electrophoresis. Gastroenterology 34, 436–449 (1958).
Santo, G. D., and S. Campus: The rate of penetration of labeled phosphate from the plasma into pathological fluids. Acta med. scand. 154, 317–323 (1956).
Schatz, C. F.: Zit. nach Gordon. Amer. J. Gastroent. 33, 15–37 (1960).
Schedl, H. P., and F. C. Bartter: An explanation for and experimental correction of the abnormal water diuresis in cirrhosis. J. clin. Invest. 39, 248–261 (1960).
Scheffler, J., u. E. Regoeczi: Unveröffentlichte Beobachtungen.
Schilling, J. A., F. W. Mckee and W. Wilt: Experimental hepaticportal arteriovenous anastomoses. Surg. Gynec. Obstet. 90, 473–480 (1950).
Schoenberger, J. A., G. Kroll, E. L. Eckert and R. M. Kark: Investigation of transfer rates of albumin tagged with I131 in ascites and edema. II. Studies in control subjects and patient with cirrhosis. J. Lab. clin. Med. 47, 227–240 (1956).
Schwartzkopff, W., U. H. Pickert: Nachweis von Austauschvorgängen zwischen Ascites und Blutbahn mittels Evans-Blau. Klin. Wschr. 34, 255–259 (1956).
Shaldon, S.: The clinical application of aldosterone antagonists in the treatment of edema. Proc. roy. Soc. Med. 54, 259–261 (1961).
Shaldon, S. J. R. Mclaren and S. SherlocK: Resistant ascites treated by combined diuretic therapy. Spirolactone, mannitol, and chlorothiazide. Lancand I, 609–613 (1960).
Sheehy, T. W., and A. Berman: The anemia of cirrhosis. J. Lab. clin. Med. 56, 72–82 (1960).
Siegenthaler, W., B. Trtjniger, W. Rutishauser, E. Lüthy U. R. Hegglin: Hämodynamik und Aldosteronausscheidung. Schweiz, med. Wschr. 91, 259–264 (1961).
Slater, J. D. H., A. Moxham, R. Hurter and J. D. N. Nabarro: Clinical and metabolic effects of aldosterone antagonism. Lancand II, 931–939 (1959).
Sleisenger, M. H., J. Richard, O. D. Kowlessar, B. Clarkson, D. Thompson and R. E. Petersen: Effects of spirolactones on excretion of water and electrolytes, and on aldosterone metabolism in cirrhosis. J. clin. Invest. 38, 1043–1044 (1959).
Snell, A. M. (as moderator): Panel: ascites. Gastroenterology 38, 129–141 (1960).
Spak, I.: On the clinical value of paper electrophoresis and of determination of muco- protein in ascitic fluid. Scand. J. clin. Lab. Invest. 10, 34–38 (1958).
Spak, I. On the clinical value of chemical analysis of ascites. Acta chir. scand. suppl. 261 (1960).
Stamler, J., L. Drefus, I. J. Lichton, E. Marcus, E. E. Hasbrouck and S. Wong: Effects of ascites formation on response to rapid water, sodium and dextran loads in intact and diabetes insipidus Ringer’s infused dogs. Amer. J. Physiol. 195, 369–372 (1958).
Starling, E. H.: The fluids of the body. The Herter lectures (New York, 1908 ). Chicago: W. T. Keener & Co. 1909.
Sterling, K.: The turnover rate of serum albumin in man as measured by I131-tagged albumin. J. clin. Invest. 30, 1228–1237 (1951).
Sterling, K. Serum albumin turnover in Laennec’s cirrhosis as measured by I131-tagged albumin. J. clin. Invest. 30, 1238–1242 (1951).
Steward, W. K., and L. W. Constable: The diuretic response to Hygroton, Mersalyt and Aldactone. Lancand 1, 523–529 (1961).
Stone, P. W., and P. A. Murphy: A method for experimental production of gradual occlusion of the portal vein. Proc. Soc. exp. Biol. (N. Y. ) 72, 255–259 (1949).
Stormont, J. M., J. Crabbe, B. Fast, S. J. Wolfe and C. S. Davidson: The effect of prednisone and amphenone on fluid and electrolyte balance and on aldosterone excretion of patients with cirrhosis and ascites. J. Lab. clin. Med. 53, 396–416 (1959).
Strub, I. H., P. J. Talso and J. B. Kirsner: Intracellular and extracellular fluid and electrolyte alterations in cirrhosis of the liver with edema and ascites. Gastroenterology 28, 163–182 (1955).
Summerskill, W. H. J., B. F. Clowdus and T. H. Casey: Clinical and metabolic changes during the development of azotemia in hepatic failure with ascites. Proc. Mayo Clin. 35, 783–791 (1960).
Swann, H. G.: Zit. nach Gordon: Amer. J. Gastroent. 33, 15–37 (1960).
Taipale, E., and E. Hokkanen: The mucoprotein levels of the ascitic and pleura fluids and their clinical significance. Acta med. scand. 155, 113–124 (1956).
Talso, P. J., N. Spafford, G. Ferenzi and H. O. Jackson: Paradoxal hyponatremia associated with congestive heart failure and with cirrhosis of the liver. Metabolism 5, 58–69 (1956).
Talso, P. J. I. H. Strub and J. B. Kirsner: The metabolism of water and electrolytes in patients with cirrhosis of the liver. J. Lab. clin. Med. 47, 210–226 (1956).
Taylor, F.: Experimental portal hypertension. Ann. Surg. 146, 683–690 (1957).
Taylor, F. W., and H. L. Egbert: Portal tension. Surg. Gynec. Obstet. 92, 64–68 (1951).
Taylor, W. J., and J. D. Myers: Occlusive hepatic venous catheterization in the study of the normal liver, cirrhosis of the liver and noncirrhotic portal hypertension. Circulation 13, 368–380 (1956).
Thomas, J. P., and F. C. Bartter: Relation between diuretic agents and aldosterone in cardiac and cirrhotic patients with sodium retention. Brit. med. J. 1, 1134–1139 (1961).
Thompson, W. P., J. L. Caughey, A. O. Whipple and L. M. Rousselot: Splenic vein pressure in congestive splenomegaly (Banti’s syndrom). J. clin. Invest. 16, 571–572 (1937).
Thorn, G. W., S. H. Armstrong and V. D. Davenport: Chemical, clinical and immunological studies on the products of human plasma fractionation. XXI. The use of salt-poor concentrated human serum albumin solution in the treatment of hepatic cirrhosis. J. clin. Invest. 25, 304–323 (1946).
Tolot, F., A. Roullet, B. Salle, R. Joud, R. Pouland and PH. Evreux: Utilisation de la spirolactone dans deux cas de cirrhose alcoolique ascitique rebelle au traitement habituel. Lyon med. 93, 1139–1150 (1961).
Turner, M. B., S. Sherlock and R. E. Steiner: Splenic venography and pressure measurements in the clinical investigation of the portal venous system. Amer. J. Med. 23, 846–859 (1957).
Tyler, F. H.: The effect of liver disease on adrenal cortical function. Amer. J. Clin. 5, 377–380 (1957).
Tyor, M. P., J. K. Aikawa and D. Cayer: Measurements of the disappearance of radioactive tagged albumin from serum and the excretion of 131I in the urine of patients with cirrhosis. Gastroenterology 21, 79–89 (1952).
Tyor, M. P., and D. Cayer: Studies with iodine-tagged albumin in cirrhotic patients. Sth. med. J. (Bgham, Ala. ) 45, 141–144 (1952).
Vachon, A., C. Besset, F. Arcadio and R. Jotjd: Les spirolactones dans le traitement des cirrhoses ascitiques. Lyon méd. 93, 1029–1043 (1961).
Vander, A. J., W. S. Wilde and R. L. Malvin: Stop flow analysis of aldosterone and steroidal antagonist SC-8109 on renal tubular sodium transport kinetics. Proc. Soc. exp. Biol. (N. Y. ) 103, 525–527 (1960).
Vanslyke, D. D., H. Wu and F. C. Mclean: Studies of gas and electrolyte equilibria in the blood. J. biol. Chem. 56, 765–849 (1923).
Vesin, P., M. Giboudeau, H. Renault and R. Cattan: Traitement de 30 cas de cirrhose ascitique par la spirolactone. Etudes cliniques and biologiques. Bull. Soc. méd. Hôp. Paris 76, 997–1005 (1960).
Veyrat, R., E. Engel, P. Ducommun and A. F. Muller: Etude de l’action natriurétique d’un antagoniste de 1’aldosterone: le spirolactone SC 9420 (Aldactone). Schweiz, med. Wschr. 90, 494–497 (1960).
Volwiler, W., J. L. Bollman and J. H. Grindlay: A comparison of two types of experimental ascites. Proc. Mayo Clin. 25, 31–33 (1950).
Volwiler, W. P. D. Goldsworthy, M. P. Macmartin, P. A. Wood, I. R. Mackay and K. Fremont-Smith: Biosynthetic determination with radioactive sulfur on turnover rates of various plasma proteins in normal and cirrhotic man. J. clin. Invest. 34, 1126–1146 (1955).
Volwiler, W. J. H. Grindlay and J. L. Bollman: The relation of portal vein pressure to the formation of ascites. An experimental study. Gastroenterology 14, 40–55 (1950).
Volwiler, W. Chronic portal vein obstruction in dogs from silica cirrhosis. Gastroenterology 24, 405–413 (1953).
Walker, R. M.: The pathology and treatment of portal hypertension. Lancand I, 729–733 (1952).
Warren, W. D., and W. H. Muller: A clarification of some hemodynamic changes in cirrhosis and their surgical treatment. Ann. Surg. 150, 413–427 (1959).
Wärter, J., P. Mandel and P. Metais: Zit. nach Baker and al., J. Lab. clin. Med. 39, 30–35 (1952).
Waser, P. G.: Kreislaufdiagnostik mit Hilfe radioaktiver Isotope. In: Künstliche radioaktive Isotope in Physiologie, Diagnostik und Therapie, Bd. II, S. 507. 2. Auflage. Berlin - Göttingen - Heidelberg: Springer 1961.
Waugh, W. H.: Local factors in the pathogenesis and course of experimental ascites. J. appl. Physiol. 13, 493–500 (1958).
Weitz, W.: Über den intraabdominellen Druck bei Ascites. Dtsch. Arch. klin. Med. 95, 257–269 (1909).
Wesson, L. G.: Glomerular and tubular factors in the renal excretion of sodium chloride. Medicine 36, 281–396 (1957).
Whelan, T. J., A. B. Mccoord and J. A. Schilling: Experimental ascites: the influence of transplantation of the kidneys to the neck. Surg. Forum 3, 510–516 (1952).
Whipple, A. O.: The problem of portal hypertension in relation to the hepatospleno- pathies. Ann. Surg. 122, 449–475 (1945).
Wiggins, R. A., M. E. Hutchin, J. V. Carbone and P. D. Doolan: Effect of spirolactone SC 8109 on renal function in normal human subjects. Proc. Soc. exp. Biol. (N. Y. ) 100, 625–627 (1959).
Wiles, C. E., W. G. Schenk and J. Lindenberg: The experimental production of portal hypertension. Ann. Surg. 136, 811–817 (1950).
Wolff, H. P., E. Buchborn U. KH. R. Koczorek: Aldosteron und Adiuretin bei Leber-kranken. In: Pathologie, Diagnostik und Therapie der Leberkrankheiten. S. 102–115. Berlin-Göttingen-Heidelberg: Springer 1957.
Wollheim, E: Kreislauf und Wasserhaushalt bei Hepatitis. Dtsch. med. Wschr. 76, 789–792 (1951).
Wyers, P. J. H., and P. J. J. Vanmünster: The disappearance of Evans blue dye from the blood in normal and nephrotic subjects. J. Lab. clin. Med. 58, 375–385 (1961).
Yamahiro, H. S., and T. B. Reynolds: Effects of ascitic fluid infusion on sodium excretion, blood volume and creatinine clearance in cirrhosis. Gastroenterology 40, 497–503 (1961). Ergebnisse d. inn. Medizin, Ii. F., Bd. 20 2
Yankopoulos, N. A., J. O. Davis, B. Kliman and R. E. Peterson: Evidence that a humoral agent stimulates the adrenal cortex to secrete aldosterone in experimental secondary hyperaldosteronism. J. clin. Invest. 38, 1278–1289 (1959).
Yosida, K. I.: Über die gruppenspezifischen Unterschiede der Transsudate, Exsudate, Sekrete, Exkrete, Organextrakte und Organzellen des Menschen und ihre rechtsmedizinische Anwendung. Z. ges. exp. Med. 68, 331–339 (1928).
Yuile, C. L., B. G. Lamson, L. L. Miller and G. H. Whipple: Conversion of plasma protein to tissue protein without evidence of protein breakdown. J. exp. Med. 93, 539–557 (1951).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1963 Springer-Verlag OHG. Berlin · Göttingen · Heidelberg
About this paper
Cite this paper
Regoeczi, E., Germer, W.D. (1963). Die Pathophysiologie und der Pathomechanismus des Ascites bei der Lebercirrhose. In: Heilmeyer, L., Schoen, R., De Rudder, B., Prader, A. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde. Ergebnisse der Inneren Medizin und Kinderheilkunde, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-94862-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-94862-6_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-94863-3
Online ISBN: 978-3-642-94862-6
eBook Packages: Springer Book Archive